Eyüpoğlu, Nesrin Damla, Olgu Erkin Çınar, Salih Aksu, Yahya Büyükaşık, Nilgün Sayınalp, Haluk Demiroğlu, Hakan Göker, Osman İlhami Özcebe, and İbrahim C. Haznedaroğlu. 2022. “Event-Free Survival in Patients With Chronic Myeloid Leukemia Receiving Front-Line Imatinib Mesylate”. Acta Medica 53 (3):277-83. https://doi.org/10.32552/2022.ActaMedica.745.